Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma

Kaushala S. Jayawardana; Sarah‐Jane Schramm; Varsha Tembe; Samuel Mueller; John F. Thompson; Richard A Scolyer; Graham J. Mann; Jean Yang

doi:10.1038/jid.2015.355

Related publications

Article2013

Identification of new prognostic biomarkers for Stage III metastatic melanoma patients

Hojabr Kakavand, Richard A Scolyer, John F. Thompson, Graham J. Mann

Article2011

Prognostic and Clinicopathologic Associations of Oncogenic <i>BRAF</i> in Metastatic Melanoma

Georgina V. Long, Alexander M. Menzies, Adnan Nagrial, Lauren E. Haydu, Anne Hamilton, Graham J. Mann, Michael Hughes, John F. Thompson, Richard A Scolyer, Richard Kefford

Article2018

Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis

Christoph Krisp, Robert Parker, Dana Pascovici, Nicholas K. Hayward, James S. Wilmott, John F. Thompson, Graham J. Mann, Georgina V. Long, Richard A Scolyer, Mark P. Molloy

Article2019

The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma

Xiaobei Zhao, Paul Little, Alan P. Hoyle, Guillaume Joe Pegna, Michele C. Hayward, Anastasia Ivanova, Joel S. Parker, David Marron, Matthew G. Soloway, Heejoon Jo, Ashley H. Salazar, Michael P. Papakonstantinou, Deeanna M. Bouchard, Katherine A. Hoadley, David W. Ollila, Jill S. Frank, Nancy E. Thomas, Paul B. Googe, J. Ashley Ezzell, Frances A. Collichio, Carrie B. Lee, H. Shelton Earp, Norman E. Sharpless, Willy Hugo,

Article2014

Determination of prognosis in metastatic melanoma through integration of clinico‐pathologic, mutation, mRNA, microRNA, and protein information

Graham J. Mann, Samuel Müller, Jean Yang, Kaushala S. Jayawardana, Sarah‐Jane Schramm, Lauren E. Haydu, John F. Thompson, Richard A Scolyer